Boehringer Ingelheim International GmbH;Boehringer Ingelheim Pharma GmbH & Co. KG
发明人:
申请号:
EP11173579.1
公开号:
EP2418207A1
申请日:
2009.05.04
申请国别(地区):
EP
年份:
2012
代理人:
摘要:
Compounds which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.